Breaking News

Henry Brothers receives construction contract for laboratory spaces

The Northern Irish company has revealed the award of $122m for the construction of an engineering hall, a cleanroom, laboratory spaces, an auditori...

Broken String secures $15M financing for DNA break mapping technology

The pharmaceutical company has announced the closing of a $15 million Series A investment round to develop its next generation sequencing (NGS)-bas...

Mironid advances finances for small molecule development

Mironid has raised $43.3 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease

Small molecules: big market opportunities

The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will b...

University funding propels new pharmaceutical company AlveoGene

AlveoGene has announced its launch following funding from universities and the securing of an exclusive licence to a proprietary and validated next...

Astella invests $3.5m in antibody drug facility

Drug producer Astella is set to submit a planning application to build a new facility in Tralee (County Kerry), Ireland, to expand its capacity to...

Compliance, antibribery and corruption in the pharmaceutical industry

Complex distribution networks, varied pricing and powerful customers make the pharmaceutical industry particularly vulnerable to fraud and corrupti...

SCHOTT Pharma reveals strong financial performance in fiscal year 2022

In a record year of growth, sales increased by 27% to EUR 821 million and EBITDA by 33% to EUR 219 million on a preliminary basis

BRIM secures $45.8 million to accelerate regenerative peptides pipeline

BRIM has raised a fund to speed up the development of the company's current clinical trials while enabling it to expand and diversify our pipeline

Microplate Dx secures $3.1m for antibody diagnostic tech

Based at the University of Strathclyde, diagnostics specialist Microplate Dx has secured seed funding to develop rapid diagnostic technology for be...

Investment, outsourcing and globalisation: key trends for 2023

The start of 2023 has been challenging for the pharmaceutical industry. Economic constraints in Europe and the United States, staffing shortages, a...

Brenntag signs multi-year partnership with Workday Human Capital

The chosen Workday HCM solution will be tailored and implemented in the course of 2023 to meet the needs of Brenntag

Mitsubishi signs agreement with Roquette for Qualicaps shares

Pharmaceutical excipients expert Roquette has signed an agreement with the MCG Group for the shares of hard capsule manufacturer Qualicaps

How soon is too soon to consider market access strategies for my specialty drug?

The answer is that it’s never too soon, advises Craig Caceci, Managing Director at Terebellum. In fact, he says, if you want to ensure your product...

AUSTAR wins contract to provide bioprocess solutions for animal cell production

The company has been chosen by Ceva Health Animal Technology to provide upstream and downstream bioprocess solutions for its animal cell production...

Can preventive care put an end to disease and virus outbreaks?

Healthcare shouldn’t be about treatment!

In Brief

Piramal reveals financial results for fourth quarter

How early stage life sciences companies can improve the odds of attracting funding

Scorpion Biological Services becomes Scorpius BioManufacturing to reflect expansion

FCE Pharma

Symbiosis announces £1 million investment in analytical testing capability

Bormioli Pharma issues its first ESG Report

BioForward - The 'Roadmap for Growth' Life Sciences Event

Brenntag issues promissory note for $641m

WuXi STA breaks ground for new pharmaceutical manufacturing facility in Middletown, Delaware

Effective Pharmaceutical GMP Audits and Self-Inspections with NSF

Besins acquires site in Belgium to prevent HRT supply line issues

ChargePoint Technology’s new facility expands into Europe

Humanigen and PCI partner to prepare for commercialisation in the UK

Effective Pharmaceutical GMP Audits and Self-Inspections with NSF

Gain immediate financial return for your surplus equipment

Croda announces new pharma business

Does medtech have a role to play in tackling the cost-of-living crisis?

Value-based Healthcare in Europe

AffyXell expands partnership with GenScript ProBio

F2G enters collaboration to commercialise antifungal agent

Bone Therapeutics enters reverse merger discussions with Medsenic

BIO CEO & Investor Conference

Bormioli Pharma presents a new, reinforced value proposition for the US market

Sygnature Discovery acquires Peak Proteins

Upperton Pharma receives ‘substantial’ investment from Inflexion

Biotech and Money London 2016